Pfizer controversially starts early-stage of trial of combined Covid/Flu vaccine
Pharmaceutical giant Pfizer has launched an early-stage study of a combined COVID/influenza vaccine. The company, which collaborates with BioNTech, said the first patient this week received a dose of the vaccine, which combines a flu …